Simultaneous PPARα activation and PPARγ suppression play a major role in hepatic lipid homeostasis as well as NAFLD and NASH, but the overexpression of PPARγ causes excessive hepatic lipid accumulation. The gene discussed is PPARG; the disease is metabolic dysfunction-associated steatohepatitis.